Our methods and digital products have been honed over 20+ years to ensure clinically meaningful evidence generation; from phase 1b through to post-market patient support programs, we translate the patient voice into actionable evidence, moving from “what’s the matter” to “what matters most” for patients and caregivers in clinical research and care.
Our multidisciplinary team of experts in outcomes measurement, health informatics, data science, and goal attainment scaling make us the research partner of choice for sponsors committed to a truly patient-centric approach.
Our Journey
SymptomGuide® Launch
- SymptomGuide® Dementia website for Caregivers launched.
- SymptomGuide® Dementia used as a secondary endpoint in a Phase III trial.
DGI Inception
- DementiaGuide Inc. founded by Dr. Kenneth Rockwood with a pioneering focus on patient-centric approaches to research.
GoalNav™ Go-Live
- DementiaGuide Inc. rebranded as DGI Clinical Inc.
- Expansion into other CNS disease areas; Parkinson’s, Schizophrenia.
- First electronic data capture platform for GAS in clinical trials, GoalNav™ 1.0, launched.
- GoalNav™ 1.0 platform used in a mild Alzheimer’s disease Phase II clinical trial.
Expansion Into Rare Disease
- SymptomGuide® reconfigured as a downloadable symptom tracking app.
- Expansion into Mild Cognitive Impairment, Hemophilia, Neurogenic Bowel & Bladder Disorders, Down Syndrome-Associated Alzheimer Disease.
Ardea Outcomes Rebrand
- DGI Clinical Inc. rebranded as Ardea Outcomes Inc.
- Launch of upgraded GoalNav™ 2.0 electronic data capture platform for clinical trials and post-market studies.
- SymptomGuide® incorporated as myGoalNav™ for remote monitoring.
- Comprehensive online GAS training program launched.
- Expansion into autism, dementia with Lewy Bodies, rare oncology, and other therapeutic areas.